Progressive Multifocal Leukoencephalopathy in a Multiple Sclerosis Patient Diagnosed after Switching from Natalizumab to Fingolimod

Background. Natalizumab- (NTZ-) associated progressive multifocal leukoencephalopathy (PML) is a severe and often disabling infectious central nervous system disease that can become evident in multiple sclerosis (MS) patients after NTZ discontinuation. Recently, novel diagnostic biomarkers for the a...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Case Rep Neurol Med
Main Authors: Sinnecker, Tim, Othman, Jalal, Kühl, Marc, Metz, Imke, Niendorf, Thoralf, Kunkel, Annett, Paul, Friedemann, Wuerfel, Jens, Faiss, Juergen
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi Publishing Corporation 2016
Assuntos:
Case Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5138460/
https://ncbi.nlm.nih.gov/pubmed/27994897
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/5876798
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares